SeromYx Systems offers GCLP-certified high-throughput assays and computational analyses to correlate antibody effector function with clinical outcomes. Applications include natural course of disease, and the development of monoclonal therapeutics, immunotherapies and vaccines. Systems serology has been increasingly recognized as the gold standard for vaccine development, and SeromYx has proudly supported numerous clients with phase 3 trials, next-generation vaccine development, vaccine breakthrough analyses, longitudinal studies and BLA-enabling studies. Through our pursuit of high-quality science and our commitment to our clients, we are continuously inspired to improve and expand upon the systems serology platform originally developed at the Ragon Institute of MGH, MIT and Harvard. Discover what SeromYx can do for you at SeromYx.com.
